Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
The role of the de novo pyrimidine biosynthetic pathway in Cryptococcus neoformans high temperature growth and virulence.
de Gontijo FA
,
Pascon RC
,
Fernandes L
,
Machado J
,
Alspaugh JA
,
Vallim MA
.
???displayArticle.abstract???
Fungal infections are often difficult to treat due to the inherent similarities between fungal and animal cells and the resulting host toxicity from many antifungal compounds. Cryptococcus neoformans is an opportunistic fungal pathogen of humans that causes life-threatening disease, primarily in immunocompromised patients. Since antifungal therapy for this microorganism is limited, many investigators have explored novel drug targets aim at virulence factors, such as the ability to grow at mammalian physiological temperature (37°C). To address this issue, we used the Agrobacterium tumefaciens gene delivery system to create a random insertion mutagenesis library that was screened for altered growth at elevated temperatures. Among several mutants unable to grow at 37°C, we explored one bearing an interruption in the URA4 gene. This gene encodes dihydroorotase (DHOase) that is involved in the de novo synthesis of pyrimidine ribonucleotides. Loss of the C. neoformans Ura4 protein, by targeted gene interruption, resulted in an expected uracil/uridine auxotrophy and an unexpected high temperature growth defect. In addition, the ura4 mutant displayed phenotypic defects in other prominent virulence factors (melanin, capsule and phospholipase) and reduced stress response compared to wild type and reconstituted strains. Accordingly, this mutant had a decreased survival rate in macrophages and attenuated virulence in a murine model of cryptococcal infection. Quantitative PCR analysis suggests that this biosynthetic pathway is induced during the transition from 30°C to 37°C, and that transcriptional regulation of de novo and salvage pyrimidine pathway are under the control of the Ura4 protein.
Ali,
Pyrimidine biosynthesis is not an essential function for Trypanosoma brucei bloodstream forms.
2013, Pubmed
Ali,
Pyrimidine biosynthesis is not an essential function for Trypanosoma brucei bloodstream forms.
2013,
Pubmed
Alspaugh,
RAS1 regulates filamentation, mating and growth at high temperature of Cryptococcus neoformans.
2000,
Pubmed
Banerjee,
Inhibition of nucleotide biosynthesis potentiates the antifungal activity of amphotericin B.
2014,
Pubmed
Banuett,
Genetics of Ustilago maydis, a fungal pathogen that induces tumors in maize.
1995,
Pubmed
Bolard,
How do the polyene macrolide antibiotics affect the cellular membrane properties?
1986,
Pubmed
Brand,
Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus.
2004,
Pubmed
Brown,
Cryptococcus neoformans, a fungus under stress.
2007,
Pubmed
Bölker,
Ustilago maydis--a valuable model system for the study of fungal dimorphism and virulence.
2001,
Pubmed
Casadevall,
Fungal virulence, vertebrate endothermy, and dinosaur extinction: is there a connection?
2005,
Pubmed
Chang,
Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence.
1994,
Pubmed
Chang,
The second capsule gene of cryptococcus neoformans, CAP64, is essential for virulence.
1996,
Pubmed
Chang,
Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans.
1998,
Pubmed
Chen,
Inhibition of dihydroorotate dehydrogenase activity by brequinar sodium.
1992,
Pubmed
Cox,
Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages.
2003,
Pubmed
Cox,
Urease as a virulence factor in experimental cryptococcosis.
2000,
Pubmed
Cox,
Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans.
2001,
Pubmed
Davidson,
A PCR-based strategy to generate integrative targeting alleles with large regions of homology.
2002,
Pubmed
Edman,
Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation.
1990,
Pubmed
Fairbanks,
Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors.
1995,
Pubmed
Feretzaki,
Genetic circuits that govern bisexual and unisexual reproduction in Cryptococcus neoformans.
2013,
Pubmed
Fonzi,
Isogenic strain construction and gene mapping in Candida albicans.
1993,
Pubmed
Fox,
Avirulent uracil auxotrophs based on disruption of orotidine-5'-monophosphate decarboxylase elicit protective immunity to Toxoplasma gondii.
2010,
Pubmed
Fromtling,
Overview of medically important antifungal azole derivatives.
1988,
Pubmed
Ghannoum,
Potential role of phospholipases in virulence and fungal pathogenesis.
2000,
Pubmed
Goldstein,
Development of Saccharomyces cerevisiae as a model pathogen. A system for the genetic identification of gene products required for survival in the mammalian host environment.
2001,
Pubmed
Greene,
Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide.
1995,
Pubmed
Guyonvarch,
Structure of the Saccharomyces cerevisiae URA4 gene encoding dihydroorotase.
1988,
Pubmed
Hegewald,
Identification of dihydroorotate dehydrogenase as a relevant drug target for 1-hydroxyquinolones in Toxoplasma gondii.
2013,
Pubmed
Idnurm,
Cryptococcus neoformans virulence gene discovery through insertional mutagenesis.
2004,
Pubmed
Idnurm,
Light controls growth and development via a conserved pathway in the fungal kingdom.
2005,
Pubmed
Idnurm,
Identification of ENA1 as a virulence gene of the human pathogenic fungus Cryptococcus neoformans through signature-tagged insertional mutagenesis.
2009,
Pubmed
Jung,
Two cation transporters Ena1 and Nha1 cooperatively modulate ion homeostasis, antifungal drug resistance, and virulence of Cryptococcus neoformans via the HOG pathway.
2012,
Pubmed
Khutornenko,
Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway.
2010,
Pubmed
Kingsbury,
Cryptococcus neoformans Ilv2p confers resistance to sulfometuron methyl and is required for survival at 37 degrees C and in vivo.
2004,
Pubmed
Kingsbury,
Novel chimeric spermidine synthase-saccharopine dehydrogenase gene (SPE3-LYS9) in the human pathogen Cryptococcus neoformans.
2004,
Pubmed
Kingsbury,
Threonine biosynthetic genes are essential in Cryptococcus neoformans.
2008,
Pubmed
Kingsbury,
Cytocidal amino acid starvation of Saccharomyces cerevisiae and Candida albicans acetolactate synthase (ilv2{Delta}) mutants is influenced by the carbon source and rapamycin.
2010,
Pubmed
Kingsbury,
Homoserine toxicity in Saccharomyces cerevisiae and Candida albicans homoserine kinase (thr1Delta) mutants.
2010,
Pubmed
Kingsbury,
Fungal homoserine kinase (thr1Delta) mutants are attenuated in virulence and die rapidly upon threonine starvation and serum incubation.
2010,
Pubmed
Ko,
Remodeling of global transcription patterns of Cryptococcus neoformans genes mediated by the stress-activated HOG signaling pathways.
2009,
Pubmed
Kopecká,
The influence of congo red on the cell wall and (1----3)-beta-D-glucan microfibril biogenesis in Saccharomyces cerevisiae.
1992,
Pubmed
Kozel,
The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.
1982,
Pubmed
Kozubowski,
Signalling pathways in the pathogenesis of Cryptococcus.
2009,
Pubmed
Kwon-Chung,
Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice.
1982,
Pubmed
Kwon-Chung,
Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans.
1986,
Pubmed
Kwon-Chung,
Selection of ura5 and ura3 mutants from the two varieties of Cryptococcus neoformans on 5-fluoroorotic acid medium.
1992,
Pubmed
Lam,
Role of Cryptococcus neoformans Rho1 GTPases in the PKC1 signaling pathway in response to thermal stress.
2013,
Pubmed
Lee,
Characterization of the complete uric acid degradation pathway in the fungal pathogen Cryptococcus neoformans.
2013,
Pubmed
Li,
Cryptococcus.
2010,
Pubmed
Liu,
Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents.
2000,
Pubmed
Livak,
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
2001,
Pubmed
McClelland,
High frequency transformation of Cryptococcus neoformans and Cryptococcus gattii by Agrobacterium tumefaciens.
2005,
Pubmed
McFadden,
Unexpected diversity in the fine specificity of monoclonal antibodies that use the same V region gene to glucuronoxylomannan of Cryptococcus neoformans.
2004,
Pubmed
Mehboob,
Structure of dihydroorotase from Bacillus anthracis at 2.6 Å resolution.
2010,
Pubmed
Mitchell,
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.
1995,
Pubmed
Morrow,
De novo GTP biosynthesis is critical for virulence of the fungal pathogen Cryptococcus neoformans.
2012,
Pubmed
Mylonakis,
Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis.
2005,
Pubmed
Nørager,
E. coli dihydroorotate dehydrogenase reveals structural and functional distinctions between different classes of dihydroorotate dehydrogenases.
2002,
Pubmed
O'Meara,
The Cryptococcus neoformans Rim101 transcription factor directly regulates genes required for adaptation to the host.
2014,
Pubmed
Odom,
Calcineurin is required for virulence of Cryptococcus neoformans.
1997,
Pubmed
Ong,
Trypanosoma brucei (UMP synthase null mutants) are avirulent in mice, but recover virulence upon prolonged culture in vitro while retaining pyrimidine auxotrophy.
2013,
Pubmed
Paiva,
New antifungal antibiotics.
2013,
Pubmed
Park,
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.
2009,
Pubmed
Pascon,
Cryptococcus neoformans methionine synthase: expression analysis and requirement for virulence.
2004,
Pubmed
Perfect,
The gene encoding phosphoribosylaminoimidazole carboxylase (ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid.
1993,
Pubmed
Perfect,
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.
2010,
Pubmed
Pitkin,
A putative cyclic peptide efflux pump encoded by the TOXA gene of the plant-pathogenic fungus Cochliobolus carbonum.
1996,
Pubmed
Price,
Plate method for detection of phospholipase activity in Candida albicans.
1982,
Pubmed
Ram,
Identification of fungal cell wall mutants using susceptibility assays based on Calcofluor white and Congo red.
2006,
Pubmed
Rex,
Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses.
2001,
Pubmed
Roy,
cis- and trans-acting regulatory elements of the yeast URA3 promoter.
1990,
Pubmed
Schiappa,
An auxotrophic pigmented Cryptococcus neoformans strain causing infection of the bone marrow.
2002,
Pubmed
Singh,
Infections of the central nervous system in transplant recipients.
2000,
Pubmed
Toffaletti,
Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA.
1993,
Pubmed
Turnbough,
Toxicity of the pyrimidine biosynthetic pathway intermediate carbamyl aspartate in Salmonella typhimurium.
1985,
Pubmed
Vandesompele,
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.
2002,
Pubmed
Varma,
Molecular and genetic analysis of URA5 transformants of Cryptococcus neoformans.
1992,
Pubmed
Varma,
Characterization of the glyceraldehyde-3-phosphate dehydrogenase gene [correction of glyceraldehyde-3-phosphate gene] and the use of its promoter for heterologous expression in Cryptococcus neoformans, a human pathogen.
1999,
Pubmed
Walton,
Novel gene functions required for melanization of the human pathogen Cryptococcus neoformans.
2005,
Pubmed
Walton,
Conserved elements of the RAM signaling pathway establish cell polarity in the basidiomycete Cryptococcus neoformans in a divergent fashion from other fungi.
2006,
Pubmed
Wang,
Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants.
1994,
Pubmed
Yang,
Molecular and genetic analysis of the Cryptococcus neoformans MET3 gene and a met3 mutant.
2002,
Pubmed
Yoshikawa,
Comprehensive phenotypic analysis of single-gene deletion and overexpression strains of Saccharomyces cerevisiae.
2011,
Pubmed
Zameitat,
Functional expression of human dihydroorotate dehydrogenase (DHODH) in pyr4 mutants of ustilago maydis allows target validation of DHODH inhibitors in vivo.
2007,
Pubmed
van der Horst,
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
1997,
Pubmed
